Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Financing
Alzheimer’s disease testing firm C2N nabs additional $15M in financing
C2N will allocate part of the additional financing to support its new generation blood test, PrecivityAD2, designed to aid in the diagnosis of Alzheimer's disease.
February 17, 2023
Simple HealthKit closes $8M in Series A financing
The Fremont, CA-based company said that its product portfolio includes diagnostic tests for sexual health, chronic conditions such as diabetes, and the tripledemic of COVID-19, respiratory syncytial virus (RSV), and influenza A and B.
February 6, 2023
HTG Molecular Diagnostics prices $10M public offering
HTG uses transcriptome-wide profiling for translational research, novel therapeutics, and clinical diagnostics across a variety of disease areas.
December 22, 2022
Avalon GloboCare announces $4M private placement of shares to support Laboratory Services MSO acquisition
The proceeds will be used toward the purchase of Laboratory Services MSO, in Costa Mesa, CA. Avalon announced in early November its acquisition of a 60% interest in Laboratory Services MSO.
December 14, 2022
Pictor launches $5M financing round to support product, market development
Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.
December 5, 2022
PictorLabs closes $15.2M financing to develop AI-based virtual staining platform
With the additional funds secured in the latest round of financing, PictorLabs intends to expand its biomarker portfolio and develop its products.
December 1, 2022
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Sherlock Biosciences secures funding to further develop CRISPR testing platform
The company said it will use the funding to further develop its CRISPR testing platform, enabling broader testing in low- and middle-income countries.
November 29, 2022
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.
November 23, 2022
Biodesix secures loan of up to $50M, announces $35.1M stock offering
The developer of diagnostic tests that combine multiomics through AI said it will use the loan to strengthen its balance sheet, reduce near-term cash use, and enable the continued growth trajectory of its core lung diagnostics business.
November 17, 2022
SQI Diagnostics secures C$2M to support manufacturing, commercialization
SQI will use the funds to support its manufacturing scale-up and commercialization of its pipeline of products in development, including the Rali-Dx IL-6 test.
November 10, 2022
Virax Biolabs closes $3.8M private placement to support development of T-cell testing technology
Virax said it will use the net proceeds from the private placement to develop and commercialize its T-cell test technology.
November 9, 2022
Osler Diagnostics raises $85M in Series C financing
Osler Diagnostics said that the Series C financing will support its portable testing platform, which aims to provide a broad menu of tests.
November 7, 2022
Page 1 of 5
Next Page
